Literature DB >> 31995205

Speech and Language Presentations of FTLD-TDP Type B Neuropathology.

Daniel J Lee1,2, Eileen H Bigio1,3, Emily J Rogalski1,4, M-Marsel Mesulam1,2.   

Abstract

Four right-handed patients who presented with an isolated impairment of speech or language had transactive response DNA-binding protein of 43 kDa (TDP-43) type B pathology. Comportment and pyramidal motor function were preserved at presentation. Three of the cases developed axial rigidity and oculomotor findings late in their course with no additional pyramidal or lower motor neuron impairments. However, in all 4 cases, postmortem examination disclosed some degree of upper and lower motor neuron disease (MND) pathology in motor cortex, brainstem, and spinal cord. Although TDP-43 type B pathology is commonly associated with MND and behavioral variant frontotemporal dementia, it is less recognized as a pathologic correlate of primary progressive aphasia and/or apraxia of speech as the presenting syndrome. These cases, taken together, contribute to the growing heterogeneity in clinical presentations associated with TDP pathology. Additionally, 2 cases demonstrated left anterior temporal lobe atrophy but without word comprehension impairments, shedding light on the relevance of the left temporal tip for single-word comprehension.
© 2020 American Association of Neuropathologists, Inc. All rights reserved.

Entities:  

Keywords:  Frontotemporal lobar degeneration; Motor neuron disease; Primary progressive aphasia; Speech apraxia; TAR DNA-binding protein

Mesh:

Substances:

Year:  2020        PMID: 31995205      PMCID: PMC7036652          DOI: 10.1093/jnen/nlz132

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  19 in total

1.  Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions with progranulin gene (PGRN) mutations.

Authors:  Keith A Josephs; Zeshan Ahmed; Omi Katsuse; Joseph F Parisi; Bradley F Boeve; David S Knopman; Ronald C Petersen; Peter Davies; Ranjan Duara; Neill R Graff-Radford; Ryan J Uitti; Rosa Rademakers; Jennifer Adamson; Matthew Baker; Michael L Hutton; Dennis W Dickson
Journal:  J Neuropathol Exp Neurol       Date:  2007-02       Impact factor: 3.685

2.  Clinicopathologic differences among patients with behavioral variant frontotemporal dementia.

Authors:  Mario F Mendez; Aditi Joshi; Kanida Tassniyom; Edmond Teng; Jill S Shapira
Journal:  Neurology       Date:  2013-01-16       Impact factor: 9.910

3.  Clinical and neuroimaging investigations of language disturbance in frontotemporal dementia-motor neuron disease patients.

Authors:  Zhe Long; Muireann Irish; Olivier Piguet; Matthew C Kiernan; John R Hodges; James R Burrell
Journal:  J Neurol       Date:  2019-02-01       Impact factor: 4.849

4.  Asymmetry and heterogeneity of Alzheimer's and frontotemporal pathology in primary progressive aphasia.

Authors:  M-Marsel Mesulam; Sandra Weintraub; Emily J Rogalski; Christina Wieneke; Changiz Geula; Eileen H Bigio
Journal:  Brain       Date:  2014-02-25       Impact factor: 13.501

5.  The northwestern anagram test: measuring sentence production in primary progressive aphasia.

Authors:  Sandra Weintraub; M-Marsel Mesulam; Christina Wieneke; Alfred Rademaker; Emily J Rogalski; Cynthia K Thompson
Journal:  Am J Alzheimers Dis Other Demen       Date:  2009-08-21       Impact factor: 2.035

6.  Rapidly progressive aphasic dementia and motor neuron disease.

Authors:  R J Caselli; A J Windebank; R C Petersen; T Komori; J E Parisi; H Okazaki; E Kokmen; R Iverson; R P Dinapoli; N R Graff-Radford
Journal:  Ann Neurol       Date:  1993-02       Impact factor: 10.422

7.  p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS.

Authors:  Safa Al-Sarraj; Andrew King; Claire Troakes; Bradley Smith; Satomi Maekawa; Istvan Bodi; Boris Rogelj; Ammar Al-Chalabi; Tibor Hortobágyi; Christopher E Shaw
Journal:  Acta Neuropathol       Date:  2011-11-19       Impact factor: 17.088

8.  A harmonized classification system for FTLD-TDP pathology.

Authors:  Ian R A Mackenzie; Manuela Neumann; Atik Baborie; Deepak M Sampathu; Daniel Du Plessis; Evelyn Jaros; Robert H Perry; John Q Trojanowski; David M A Mann; Virginia M Y Lee
Journal:  Acta Neuropathol       Date:  2011-06-05       Impact factor: 17.088

9.  Expansion of the classification of FTLD-TDP: distinct pathology associated with rapidly progressive frontotemporal degeneration.

Authors:  Edward B Lee; Sílvia Porta; G Michael Baer; Yan Xu; EunRan Suh; Linda K Kwong; Lauren Elman; Murray Grossman; Virginia M-Y Lee; David J Irwin; Vivianna M Van Deerlin; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2017-01-27       Impact factor: 17.088

10.  The clinical, neuroanatomical, and neuropathologic phenotype of TBK1-associated frontotemporal dementia: A longitudinal case report.

Authors:  Carolin A M Koriath; Martina Bocchetta; Emilie Brotherhood; Ione O C Woollacott; Penny Norsworthy; Javier Simón-Sánchez; Cornelis Blauwendraat; Katrina M Dick; Elizabeth Gordon; Sophie R Harding; Nick C Fox; Sebastian Crutch; Jason D Warren; Tamas Revesz; Tammaryn Lashley; Simon Mead; Jonathan D Rohrer
Journal:  Alzheimers Dement (Amst)       Date:  2016-11-03
View more
  2 in total

1.  Neuropathological fingerprints of survival, atrophy and language in primary progressive aphasia.

Authors:  M Marsel Mesulam; Christina A Coventry; Eileen H Bigio; Jaiashre Sridhar; Nathan Gill; Angela J Fought; Hui Zhang; Cynthia K Thompson; Changiz Geula; Tamar Gefen; Margaret Flanagan; Qinwen Mao; Sandra Weintraub; Emily J Rogalski
Journal:  Brain       Date:  2022-06-30       Impact factor: 15.255

Review 2.  Primary progressive aphasia and motor neuron disease: A review.

Authors:  Edoardo Nicolò Aiello; Sarah Feroldi; Giulia De Luca; Lucilla Guidotti; Eleonora Arrigoni; Ildebrando Appollonio; Federica Solca; Laura Carelli; Barbara Poletti; Federico Verde; Vincenzo Silani; Nicola Ticozzi
Journal:  Front Aging Neurosci       Date:  2022-09-08       Impact factor: 5.702

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.